Document is current
Any future updates will be listed below
-
Authors
Dahl, Thomas https://orcid.org/0000-0003-4642-4346
Zammit, Gary
Ahmad, Maha
Rosenberg, Russell
Chen, Lan Bo
Roth, Thomas
- License Information
-
More Information
Article History
Received: 26 January 2021
Accepted: 27 June 2021
First Online: 8 July 2021
Declarations
:
: This study was entirely funded by Sequential Medicine, Ltd. Lan Bo Chen is the founder of Sequential Medicine. Thomas Dahl and Thomas Roth are consultants to the company. The remaining authors have no financial interests in or conflict with the subject matter or materials discussed.
: The trial was performed in compliance with Good Clinical Practice (ICH GCP), applicable regulatory requirements, and the current Declaration of Helsinki. It was registered at (Registration Number NCT 03331042). Subjects provided written informed consent.
